Literature DB >> 25728223

Demographics and treatment of adolescent posttraumatic headache in a regional concussion clinic.

Harry Bramley1, Steven Heverley2, Mechelle M Lewis3, Lan Kong3, Rowena Rivera3, Matthew Silvis3.   

Abstract

OBJECTIVE: Mild traumatic brain injury affects over one million pediatric patients annually. Minimal data and no guidelines exist regarding treatment of posttraumatic headache (PTH). The current study investigated treatment and outcomes in patients with posttraumatic headache.
METHODS: Medical records of all patients (age 13-18 years of age) seen at a regional concussion program from 2006 to 2011 were reviewed. Statistical analysis using SAS 9.2 was conducted to determine the effectiveness of treatment as well as the association of gender, concussion history, and football participation on the duration of posttraumatic headache.
RESULTS: Four hundred subjects met the inclusion criteria. Females were more likely to report posttraumatic headache than males (90% vs. 79%, P = 0.004), more likely to be prescribed amitriptyline (24% vs. 13%, P = 0.004), and had a significantly longer recovery time (median, 80 days versus 34 days, P < 0.001). Seventeen percent of subjects were prescribed amitriptyline for treatment of posttraumatic headache, of which 82% reported a beneficial effect. There was no difference in the percentage of posttraumatic headache or recovery time in football players versus other male athletes from other sport mechanisms.
CONCLUSION: Females are more likely to report posttraumatic headache than males and also take longer to recover. Amitriptyline appears to be well-tolerated and an effective treatment strategy for patients with posttraumatic headache. Among pediatric patients evaluated in a concussion clinic, there is no difference in the proportion of football players reporting headaches compared with male players of other sports.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  amitriptyline; concussion; headache; mild traumatic brain injury; treatment

Mesh:

Substances:

Year:  2015        PMID: 25728223     DOI: 10.1016/j.pediatrneurol.2015.01.008

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  8 in total

Review 1.  Post-Concussive Syndrome: a Focus on Post-Traumatic Headache and Related Cognitive, Psychiatric, and Sleep Issues.

Authors:  Mia T Minen; Alexandra Boubour; Harjasleen Walia; William Barr
Journal:  Curr Neurol Neurosci Rep       Date:  2016-11       Impact factor: 5.081

Review 2.  Pediatric Mild Traumatic Brain Injury in the Acute Setting.

Authors:  Daniel J Corwin; Matthew F Grady; Mark D Joffe; Mark R Zonfrillo
Journal:  Pediatr Emerg Care       Date:  2017-09       Impact factor: 1.454

3.  Practice Current: How do you diagnose and treat post-concussive headache?

Authors:  Ajal Dave; Aravind Ganesh; Malik Muhammad Adil; Jack W Tsao
Journal:  Neurol Clin Pract       Date:  2019-06

Review 4.  Pharmacotherapy for Persistent Posttraumatic Headaches in Children and Adolescents: A Brief Review of the Literature.

Authors:  Joanne Kacperski
Journal:  Paediatr Drugs       Date:  2018-10       Impact factor: 3.022

5.  Sex Differences in Traumatic Brain Injury: What We Know and What We Should Know.

Authors:  Raeesa Gupte; William Brooks; Rachel Vukas; Janet Pierce; Janna Harris
Journal:  J Neurotrauma       Date:  2019-07-19       Impact factor: 5.269

Review 6.  Acute and chronic management of posttraumatic headache in children: A systematic review.

Authors:  Carlyn Patterson Gentile; Ryan Shah; Samantha L Irwin; Kaitlin Greene; Christina L Szperka
Journal:  Headache       Date:  2021-12-04       Impact factor: 5.311

Review 7.  The Molecular Pathophysiology of Concussion.

Authors:  David R Howell; Julia Southard
Journal:  Clin Sports Med       Date:  2021-01       Impact factor: 2.186

Review 8.  Pharmacologic Therapies for Pediatric Concussions.

Authors:  Mark E Halstead
Journal:  Sports Health       Date:  2016 Jan-Feb       Impact factor: 3.843

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.